Miranda, A.; Lopez-Blanco, R.; Lopes-Nunes, J.; Melo, A.M.; Campello, M.P.C.; Paulo, A.; Oliveira, M.C.; Mergny, J.-L.; Oliveira, P.A.; Fernandez-Megia, E.;
et al. Gallic Acid–Triethylene Glycol Aptadendrimers Synthesis, Biophysical Characterization and Cellular Evaluation. Pharmaceutics 2022, 14, 2456.
https://doi.org/10.3390/pharmaceutics14112456
AMA Style
Miranda A, Lopez-Blanco R, Lopes-Nunes J, Melo AM, Campello MPC, Paulo A, Oliveira MC, Mergny J-L, Oliveira PA, Fernandez-Megia E,
et al. Gallic Acid–Triethylene Glycol Aptadendrimers Synthesis, Biophysical Characterization and Cellular Evaluation. Pharmaceutics. 2022; 14(11):2456.
https://doi.org/10.3390/pharmaceutics14112456
Chicago/Turabian Style
Miranda, André, Roi Lopez-Blanco, Jéssica Lopes-Nunes, Ana M. Melo, Maria Paula Cabral Campello, António Paulo, Maria Cristina Oliveira, Jean-Louis Mergny, Paula A. Oliveira, Eduardo Fernandez-Megia,
and et al. 2022. "Gallic Acid–Triethylene Glycol Aptadendrimers Synthesis, Biophysical Characterization and Cellular Evaluation" Pharmaceutics 14, no. 11: 2456.
https://doi.org/10.3390/pharmaceutics14112456
APA Style
Miranda, A., Lopez-Blanco, R., Lopes-Nunes, J., Melo, A. M., Campello, M. P. C., Paulo, A., Oliveira, M. C., Mergny, J.-L., Oliveira, P. A., Fernandez-Megia, E., & Cruz, C.
(2022). Gallic Acid–Triethylene Glycol Aptadendrimers Synthesis, Biophysical Characterization and Cellular Evaluation. Pharmaceutics, 14(11), 2456.
https://doi.org/10.3390/pharmaceutics14112456